Omentin reduces venous neointimal hyperplasia in arteriovenous fistula through hypoxia-inducible factor-1 alpha inhibition
Microvascular Research · 2024
DOI: 10.1016/j.mvr.2024.104688 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microvascular Research, 2024. Verfasst von Li Zhui und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Electronic address: lizhui051…. Hauptthemen laut MEDLINE: Hyperplasia, Neointima, Hypoxia-Inducible Factor 1, alpha Subunit, Cytokines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Arteriovenous fistula (AVF) failure often involves venous neointimal hyperplasia (VNH) driven by elevated hypoxia-inducible factor-1 alpha (HIF-1α) in the venous wall. Omentin, known for its anti-inflammatory and anti-hyperplasia properties, has an uncertain role in early AVF failure. This study investigates omentin's impact on VNH using a chronic renal failure (CRF) rabbit model. The CRF rabbit model of AVF received omentin-expressing adenoviral vector or control β-gal vector to assess omentin's effects on VNH. Human vascular smooth muscle cells (HVSMCs), stimulated with tumor necrosis factor-α (TNF-α), were exposed to recombinant human omentin (Rh-OMT) to study its influence on cell proliferation and migration. The AMP-activated protein kinase (AMPK) inhibitor compound C and the mammalian target of rapamycin (mTOR) activator MHY1485 were employed to explore omentin's mechanisms in VNH reduction through HIF-1α inhibition. Omentin treatment reduced VNH in CRF rabbits, concomitant with HIF-1α down-regulation and the suppression of downstream factors, including vascular endothelial growth factor and matrix metalloproteinases. Rh-OMT inhibited TNF-α-induced HVSMC proliferation and migration by modulating both cell cycle and cell adhesion proteins. Additionally, omentin reduced HIF-1α expression through the AMPK/mTOR pathway activation. Notably, the blockade of AMPK/mTOR signaling reversed omentin-mediated inhibition of VNH, cell proliferation, and migration, both in vivo and in vitro. In conclusion, omentin mitigates VNH post-AVF creation by restraining HIF-1α via AMPK/mTOR signaling. Strategies boosting circulating omentin levels may offer promise in averting AVF failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Electronic address: lizhui0511@126.com.
- Department of Vascular Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Zitieren
APA
Zhui, L., Yuling, C., Hansheng, W., & Xiangjie, L. (2024). Omentin reduces venous neointimal hyperplasia in arteriovenous fistula through hypoxia-inducible factor-1 alpha inhibition. Microvascular Research. https://doi.org/10.1016/j.mvr.2024.104688
Vancouver
Zhui L, Yuling C, Hansheng W, Xiangjie L. Omentin reduces venous neointimal hyperplasia in arteriovenous fistula through hypoxia-inducible factor-1 alpha inhibition. Microvascular Research. 2024. doi:10.1016/j.mvr.2024.104688
BibTeX
@article{Zhui2024,
author = {Zhui, Li and Yuling, Chen and Hansheng, Wang and Xiangjie, Li},
title = {Omentin reduces venous neointimal hyperplasia in arteriovenous fistula through hypoxia-inducible factor-1 alpha inhibition},
journal = {Microvascular Research},
year = {2024},
doi = {10.1016/j.mvr.2024.104688}
}
EUVIMED